From an artificial pancreas to a cancer trial with 84 per cent efficacy, here are some highlights from SCMP's recent science ...

GLP-1 receptor agonist use in patients with diabetes aims to mitigate cardiovascular kidney and metabolic risk.

Weight loss also increased with the dose. Participants receiving 4 mg, 9 mg, or 12 mg of retatrutide lost an average of 11.5% ...

Could a new drug that makes fat cells self-destruct be the next big GLP-1? CBL-514 targets fat cells, and a new study shows that it was effective in slimming down participants’ ...

Petah Tikva-based DreaMed Diabetes has just received FDA 510(k) clearance for MODI, a prescription medical application that automatically optimizes insulin dosing for adults with type 2 diabetes. For ...

DreaMed Diabetes has received FDA 510(K) clearance for MODI, a tool that uses continuous glucose monitoring data to provide insulin dosing recommendations for people with Type 2 diabetes who need both ...

The US Food and Drug Administration has approved Eli Lilly’s once-weekly basal insulin, Onswik, for adults with type 2 diabetes, the drugmaker said on Thursday, offering patients ‌an alternative to ...

Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly said it has received FDA approval for a new once-weekly insulin injection for people with type 2 diabetes. (Photo by ...

Eli Lilly says the U.S. Food and Drug Administration has approved its new once-weekly insulin injection for people with type 2 diabetes. The new medication is designed to be used alongside diet and ...

The US Food and Drug Administration has officially approved Eli Lilly’s once-weekly basal insulin for adults with type 2 diabetes- a move that offers patients an alternative to daily long-acting ...